scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JAMCOLLSURG.2006.10.004 |
P698 | PubMed publication ID | 17189106 |
P50 | author | Atsushi Kudo | Q51752767 |
P2093 | author name string | Shinji Tanaka | |
Shigeki Arii | |||
Noriaki Nakamura | |||
Kenichi Teramoto | |||
Koji Ito | |||
Takanori Ochiai | |||
Toru Kawamura | |||
Norio Noguchi | |||
P433 | issue | 1 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
hepatectomy | Q1514021 | ||
resectable hepatocellular carcinoma | Q19000460 | ||
P304 | page(s) | 1-6 | |
P577 | publication date | 2006-11-28 | |
P1433 | published in | Journal of the American College of Surgeons | Q15723630 |
P1476 | title | Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: Rationale for partial hepatectomy as first strategy. | |
P478 | volume | 204 |
Q53664285 | A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma. |
Q45690180 | Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial |
Q34585759 | Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy |
Q35452945 | Factors affecting prognosis of small hepatocellular carcinoma in Taiwanese patients following hepatic resection |
Q35207733 | Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians |
Q42685478 | Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria |
Q26765182 | Hepatocellular carcinoma: Where are we? |
Q37235259 | Hepatocellular carcinoma: defining the place of surgery in an era of organ shortage |
Q43436743 | Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria |
Q41137427 | Intention to treat survival following liver transplantation for hepatocellular carcinoma within a donor service area |
Q50072154 | Liver Resection and Surgical Strategies for Management of Primary Liver Cancer |
Q33437967 | Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis |
Q42588893 | Medical treatment of hepatocellular carcinoma |
Q37821302 | Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib |
Q37639189 | Medical treatments: in association or alone, their role and their future perspectives: novel molecular-targeted therapy for hepatocellular carcinoma |
Q37722656 | Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma |
Q87015676 | Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma |
Q36016223 | Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma |
Q35924626 | Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease |
Q82069815 | Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study |
Q55033899 | Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology. |
Q37485623 | Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection |
Q38128370 | Radiofrequency ablation for hepatocellular carcinoma |
Q30410247 | Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria? |
Q37848247 | Resection of a transplantable single-nodule hepatocellular carcinoma in Child-Pugh class A cirrhosis: factors affecting survival and recurrence. |
Q50080278 | Role of Hepatic Resection for HCC in the era of Transplantation; an Experience of Two Tertiary Egyptian Centers. |
Q42172365 | Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis |
Q38048224 | Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria |
Q42254863 | Triple positive tumor markers predict recurrence and survival in early stage hepatocellular carcinoma |
Q47137057 | Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional visualization operative treatment planning system and percutaneous transhepatic cholangial drainage with intraductal chilled saline perfusion for larger hepatic hilum he |
Q39359414 | Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy |
Search more.